000 01305 a2200373 4500
005 20250516055611.0
264 0 _c20120612
008 201206s 0 0 eng d
022 _a1365-2125
024 7 _a10.1111/j.1365-2125.2011.04105.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBigot, Adrien
245 0 0 _aPeriprandial administration of inhaled iloprost: a risk factor for digestive bleeding?
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_cMar 2012
300 _a484-5 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAdministration, Inhalation
650 0 4 _aAged
650 0 4 _aEating
650 0 4 _aFemale
650 0 4 _aGastrointestinal Hemorrhage
_xchemically induced
650 0 4 _aHumans
650 0 4 _aHypertension, Pulmonary
_xdrug therapy
650 0 4 _aIloprost
_xadverse effects
650 0 4 _aMale
650 0 4 _aRisk Factors
650 0 4 _aVasodilator Agents
_xadverse effects
700 1 _aJonville-Bera, Annie-Pierre
700 1 _aDiot, Elisabeth
700 1 _aMagro, Pascal
700 1 _aDiot, Patrice
773 0 _tBritish journal of clinical pharmacology
_gvol. 73
_gno. 3
_gp. 484-5
856 4 0 _uhttps://doi.org/10.1111/j.1365-2125.2011.04105.x
_zAvailable from publisher's website
999 _c21187779
_d21187779